Dapagliflozin mitigates ovalbumin-prompted airway inflammatory-oxidative successions and associated bronchospasm in a rat model of allergic asthma.

Manar Mohammed El TabaaAliaa Mohammed Kamel FattahMohamed ShaalanEman RashadNageh Ahmed El Mahdy

Published in: Expert opinion on therapeutic targets (2022)

DAPA presents a new prospective possibility for future asthma therapy due to its anti-inflammatory, anti-oxidant, and bronchodilator properties. DAPA has the property of reducing Dexamethasone (DEXA)-associated unfavorable effects during asthma treatment.

Keyphrases

allergic rhinitis
chronic obstructive pulmonary disease
lung function
anti inflammatory
oxidative stress
low dose
high dose
cystic fibrosis
stem cells
radiation therapy
current status
radiation induced
bone marrow
combination therapy
replacement therapy